Top compounds associated with response to FZD3


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA EX-527 GDSC1000 pan-cancer AAC 0.12 0.0006
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.11 0.0007
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA barasertib CTRPv2 pan-cancer AAC 0.11 0.0007
Download CSV